pramipexole has been researched along with Disease Exacerbation in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Buonvicino, D; Chiarugi, A; Gerace, E; Guasti, D; Muzzi, M; Pratesi, S; Ranieri, G; Tofani, L | 1 |
| Wang, T; Ying, M; Zhang, L; Zhao, R; Zhu, D | 1 |
| Dutra, RC; Felipetti, FA; Gonçalves, ECD; Horewicz, VV; Lieberknecht, V; Martins, DF; Rabelo, BD; Rodrigues, ALS | 1 |
| Cho, YW; Jeon, JY; Lee, HB; Moon, HJ; Song, ML | 1 |
| Ascherio, A; Cudkowicz, ME; Johns, DR; Leitner, M; Liu, D; O'Reilly, ÉJ; Paganoni, S; Schwarzschild, MA | 1 |
| Henry, C; Masson, M | 1 |
| Inoue, Y; Ito, E; Kobayashi, M; Matsui, K; Nakamura, M; Nishida, S; Takahashi, M; Usui, A | 1 |
| Armand, C; Cochran, J; François, C; Haycox, A; Murteira, S | 1 |
| Jennings, D; Marek, K; Seibyl, J | 1 |
| Bergmans, P; Booij, J; Stoof, JC; van Royen, EA; Winogrodzka, A; Wolters, EC | 1 |
| Morrish, PK | 1 |
| Montgomery, EB | 1 |
| Schapira, AH | 1 |
| Dooley, M; Markham, A | 1 |
3 review(s) available for pramipexole and Disease Exacerbation
| Article | Year |
|---|---|
Do dopamine agonists or levodopa modify Parkinson's disease progression?
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes | 2002 |
Present and future drug treatment for Parkinson's disease.
Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence | 2005 |
Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Disease Progression; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome | 1998 |
3 trial(s) available for pramipexole and Disease Exacerbation
| Article | Year |
|---|---|
Serum urate at trial entry and ALS progression in EMPOWER.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Antioxidants; Benzothiazoles; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; International Cooperation; Male; Middle Aged; Pramipexole; Sex Factors; Survival Analysis; Uric Acid; Young Adult | 2017 |
Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Disability Evaluation; Disease Progression; Early Diagnosis; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Quality of Life; Time; Treatment Outcome | 2009 |
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain; Cocaine; Disease Progression; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Degeneration; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Regression Analysis; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |
10 other study(ies) available for pramipexole and Disease Exacerbation
| Article | Year |
|---|---|
Neuroprotection induced by dexpramipexole delays disease progression in a mouse model of progressive multiple sclerosis.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Progression; Female; Humans; Mice; Multiple Sclerosis; Neuroprotection; Pramipexole | 2020 |
Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
Topics: Adult; Aged; China; Disease Progression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Retrospective Studies | 2022 |
Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis.
Topics: Anhedonia; Animals; Axons; Brain-Derived Neurotrophic Factor; Corpus Striatum; Depression; Disease Progression; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Interleukin-1beta; Lymph Nodes; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Oxidative Stress; Peptide Fragments; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Single-Blind Method; Spinal Cord | 2021 |
Augmentation in restless legs syndrome patients in Korea.
Topics: Aged; Aged, 80 and over; Amines; Benzothiazoles; Cross-Sectional Studies; Cyclohexanecarboxylic Acids; Disease Progression; Dopamine Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Korea; Long-Term Care; Male; Middle Aged; Pramipexole; Pregabalin; Restless Legs Syndrome; Risk Factors | 2015 |
[Depression following mania: A specific entity in bipolar disorder?]
Topics: Benzothiazoles; Bipolar Disorder; Depression; Disease Progression; Dopaminergic Neurons; Humans; Pramipexole; Suicidal Ideation | 2017 |
Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study.
Topics: Aged; Benzothiazoles; Disease Progression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Retrospective Studies; Risk Factors; ROC Curve; Time Factors | 2017 |
Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluation.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Cost-Benefit Analysis; Disease Progression; Dopamine Agonists; Female; Health Care Costs; Humans; Indans; Insurance, Health, Reimbursement; Male; Markov Chains; Middle Aged; Models, Economic; Monoamine Oxidase Inhibitors; Monte Carlo Method; Parkinson Disease; Pramipexole; Probability; Quality-Adjusted Life Years; State Medicine; Treatment Outcome; United Kingdom | 2009 |
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Caudate Nucleus; Cocaine; Corpus Striatum; Disease Progression; Female; Humans; Male; Nerve Degeneration; Parkinson Disease; Pergolide; Pramipexole; Putamen; Radiopharmaceuticals; Receptors, Dopamine D2; Reproducibility of Results; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2003 |
REAL and CALM: what have we learned?
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression; Dopamine; Feasibility Studies; Humans; Indoles; Levodopa; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Putamen; Reference Values; Sensitivity and Specificity; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Slowing Parkinson's disease progression: recent dopamine agonist trials.
Topics: Antiparkinson Agents; Artifacts; Benzothiazoles; Clinical Trials as Topic; Disease Progression; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Severity of Illness Index; Single-Blind Method; Thiazoles | 2004 |